Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes by unknown
RECOGNITION BY PREGNANCY SERUMS OF NON-HL-A
ALLOANTIGENS SELECTIVELY EXPRESSED ON B
LYMPHOCYTES*
By R. J. WINCHESTER,t S. M. FU, P. WERNET, H. G. KUNKEL, B. DUPONT,
AND C. JERSILD
(From the Rockefeller University and the Memorial Sloan-Kettering Cancer Center,
New York, 10021)
Materials and Methods
Brief Definitive Report
The value of pregnancy serums for HL-A typing is well recognized (1). Most of
the specific antibodies in these serums arise through immunization ofthe mother
by the foreign HL-A antigens of the fetus. These determinants are found on all
peripheral blood lymphocytes and are primarily detected in microcytotoxicity
assays (1, 2).
In addition to the HL-A antigens, the histocompatability complex on the
lymphocyte surface also includes the structures determining the mixed lympho-
cyte reaction (MLR). Although these remain undefined, certain pregnancy
serums are known to selectively inhibit the MLR (3), and the serologic
characterization of these MLR-related structures has been initiated (4). In the
mouse an additional series of serologically defined determinants, the la system
has been described recently that appears to map with immune response genes
(5).
In the present study a large scale screening program of pregnancy serums was
initiated in an effort to detect isoantibodies other than those to HL-A antigens
which might relate more directly to the specificities detected in the MLR system .
A modified procedure of indirect immunofluorescence was utilized for the
analysis of a variety of different B and T lymphocytes exposed to the sera. A
significant number of the sera showed selective staining ofB cells with a clearly
defined specificity pattern for cells from different individuals.
Cell Preparation. Mononuclear cells were isolated on Ficoll-Hypaque discontinuous gradients
from the peripheral blood of pregnant women, nonpregnant normal individuals, and patients with
chronic lymphaticleukemia. Single cell suspensions of thymus were similarly purified . Thecellswere
washed three times with phosphate-buffered saline, 0.1% glucose (PBS-G) and suspended in Hanks'
balanced salt solution. Thecellswere incubatedwith latexparticles for 1 h at 37°C andwashed twice
with PBS-G. They were suspended in PBS with 2% bovine serum albumin and 0.02% sodium azide
(PBS-BSA) at a concentration of 2 x 10' lymphocytes per ml (6). Human lymphoid lines were
maintained in medium RPMI 1640 supplemented with 10% fetal calf serum. They were gently
washed with PBS-BSAthreetimesandsuspended at aconcentration of 1 x 10' perml. Preparation of
enriched T- and B-lymphocyte populations was made by Ficoll-Hypaque discontinuous gradient to
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separate nonrosette-formingB lymphocytes from the T cells that rosette with sheep erythrocytes as
described previously (7) .
Serum Preparation .
￿
Normal serums were obtained from male and female laboratory personnel
that have not been isoimmunized . Unselected pregnancy serums were obtained at the time of
delivery . The serums were used without dilution after heat inactivation .
Immunofluorescence . Indirect immunofluorescent staining was performed as described previ-
ously (6) with modifications . Briefly, 5 x 10' lymphocyteswere incubated for 30 min with 0.025 ml of
either a pregnancy serum or a normal serum in 10 x 75 mm plastic tubes precoated with BSA. After
four washings with PBS-BSA, the lymphocytes were stained for30 minwith the F(ab') z fragments of
a rabbit antiserum specific for human IgG (8) . After three washings with PBS-BSA, the cells were
processed for examination by fluorescent microscopy . All the above procedures were performed at
room temperature . Direct staining with F(ab') 2 reagents specific for p- andS-determinants was used
to detect lymphocytes with surfaceimmunoglobulins as described previously (8) . The presence of an
Fe receptor was detected by incubating the cells at 4°C with 10 gg of human IgG labeled with
tetramethyl rhodamineand 0.05 ml of whole rabbit anti-IgG conjugated with tetramethyl rhodamine,
added consecutively . This method gave results in detecting Fc receptors on lymphocytes similar to
the aggregated IgG assay used previously (7) .
Cytotoxicity .
￿
Screening of serums was carried out on apanel of normal lymphocytes, and all cell
typing was performed by the one state microcytotoxicity method according to Kissmeyer-Nielsen
(2) . Subsequent microcytotoxicity, using the selected serums, were performed by the two-stage assay
(9) .
Results
Since preliminary results indicated that antibodies specific for B cells were of
special interest, 320 pregnancy ,serums were screened by immunofluorescence for
IgG antibodies that reacted with either of two B-cell lines, RPMI 1788 and
B35M . Only strongly staining serums as shown in Fig . 1, were selected . Serums
with antibodies cytotoxic for a panel of HL-A-defined peripheral blood lympho-
cytes (PBL) were excluded leaving 32 that showed strong staining of one or both
B-cell lines . These serums were then tested against normal PBL by immunofluo-
rescence . Many brightly stained from 5 to 20% of the PBL including theB cells
and did not detect determinants present on the vast majority ofT cells as shown
in Table I . Several serums stained T cells weakly and required absorption to
eliminate noncytotoxic anti-HL-A antibodies . In Table I the number of cells
TABLEI
Percent Staining of Peripheral Blood Lymphocytes from Representative Individuals by
Pregnancy Serums in Indirect Immunofluorescence
' Membrane Ig refers to the % of cells bearing either IgM or IgD or both . NT, not tested .
Serum
CD
Cells from
normal
FJ
individuals
MH 127
Cells from
pregnancy serum donor
057
Pregnancy serum
058 15 <2 18 2 12
057 10 <2 13 10 <2
127 5 <2 11 2 NT
111 12 8 2 10 NT
Normal serum < 2 < 2 <2 <2 <2
Surface markers
Membrane Ig* 8 3 11 8 11
Fe receptor 15 8 14 6 10926
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stained equalled or slightly exceeded the number with Fe receptors and was
greater than the number with membrane Ig. These serums gave patterns of con-
siderable specificity in their reactions with different normal subjects as shown in
Table I, and did not react with autologous lymphocytes. Thebackground staining
of normal serums was under two percent.
Monocytes from different subjects also were brilliantly stained and this
staining was found in association with positive B-lymphocyte staining as shown
in Fig. 1; it could be readily differentiated from the background staining seen
upon incubation with normal serums. Thymocytes from three individuals were
studied. At least 90% of the cells were negative but 10% of the cells stained in one
instance. Some staining of stimulated PBL T cells was also observed. The stain-
ing reactions of purified preparations of normal B and T lymphocytes from PBL
are shown in Fig. l.
The pattern of specificity shown by the serums for determinants on peripheral
blood lymphocyteswas further explored on B-cell lymphoid lines and leukemic B
lymphocytes (Table 11). The positive staining of the B-lymphoid lines was often
extremely brilliant, and included 100% of the cells; it contrasted with the
negative reactions which for most lines was the absence of any staining of viable
cells. Certain lines showed weak positive fluorescence, with all normal serums; if
this caused interpretive difficulties, the lines were excluded from the study. All
serums failed to stain the T-cell line MOLT 4F. The staining of the leukemic B
lymphocytes from nine patients showed asimilarpattern of positive and negative
reactivity. Surface lg, intracellular 1g, Fc receptors, and HL-A type were
determined and did not appear to influence the results of the staining with the
B-cell lines or leukemic lymphocytes.
The antibody specificity was also readily demonstrated in a two-stage
microcytotoxicity assay. The results of fluorescence and cytotoxicity were in
general agreement. For example, serum 172 shows no cytotoxicity for cell lines
6410 and MOLT 4F, 72% killing of 7301 and 29% for 1788 ; and serum 007 kills
100% of cell lines 6410 and B35M, 68% of 7301, and 35% of 1788 and is without
cytotoxicity for MOLT 4F. Similar results were obtained with enriched prepara-
tions of peripheral blood B cells.
Discussion
The studies described above demonstrate that some pregnancy sera contain
antibodies that are reactive with B cells and not visibly with T lymphocytes.
B-cell lymphoid lines, normal peripheral blood B cells, and CLL B cells all
showed positive fluorescence reactions while preparations of normal peripheral
blood T cells and thymocytes were essentially negative. These sera were selected
in a large scale fluorescence screening procedure utilizing the B-cell lymphoid
lines and normal peripheral blood T cells as,target cells. HL-A antibodies were
excluded by their reactivity with both types of cells by fluorescence as well as
through the usual cytotoxic screening with a panel of cells. However, it was clear
that some sera containing HL-A antibodies also contained the B-cell reactive
type and after absorption either with T cells or platelets were specific for B cells.
Through the use of a panel of 11 different B-cell lymphoid lines, clear
differential patterns of fluorescence were obtained with individual selected sera.WINCHESTER ET AL .
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FIG . 1 . Illustration of the fluorescence obtained on incubating the selectively screened
pregnancy serums with purified preparations of normal peripheral blood cells from a positive
donor and with cells from a positive lymphoid line . (a) phase micrograph of an enriched
preparation of rosette-forming T lymphoctyes . (b) fluorescent micrograph of the same field
showing only a single-stained lymphocyte . (c) fluorescence of a comparably enriched non
rosette forming preparation of mononuclear cells composed primarily ofB lymphocytes . The
arrow indicates a monocyte identified under phase microscopy by latex ingestion . (d) bright
fluorescence of one positive B-cell lymphoid line .
Cells positive with one serum were negative with another and vice versa . It was
apparent that a large number of different antigen-antibody systems were
involved and considerable further work will be required to delineate the specific
markers . Analyses of peripheral bloodB cells from individual donors proved more
difficult but through a series of improvements in the indirect fluorescence
method, particularly the use of F(ab') 2 reagents, these problems were largely
overcome . Again differential patterns of normal B cells similar to those for the
cell lines were obtained . Because of the low numbers of B cells in normal
peripheral blood, it frequently proved advantageous to concentrate the B-cell
population . Monocytes were also positive in individuals where the B cells were
positive and negative in the others . This was also true of the so-called "third
population" of lymphocytes with Fc receptors but no surface IgM and IgD (8) .
The maternal cells of the serum donor were clearly negative with autologous
serum in each instance studied . Since it was apparent from these data as well as
family studies that another alloantigen-antibody system was involved, it was
termed HL-B . However the possibility of multiple genetic systems remains.
Assays by cytotoxicity paralleled those by fluorescence . Previous failures to
detect these antibodies by cytotoxic analysis appears to be due to the low
numbers ofB cells in normal peripheral blood . This can be overcome by specific
enrichment of theB cells . Previous studies of human lymphoid lines with HL-A
antisera have led to the postulation that "blast" antigens are present and explain
a variety of anomolous reactivities (10, 11) . Absorption studies demonstrated
that the antigens described above were not of this type . Studies in the author's928
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TABLE II
Representative Reactions Given by Selected Pregnancy Serums on Lymphocytes from
Leukemic Patients andLymphoid Lines in Indirect Immunofluorescence
' Numbers (1-4+) refer to definite positive staining of over 90% of cells with an estimate of fluorescence intensity .
laboratory of a special serum PL which had been shown to block strongly the
MLR reaction (3) indicated that this serum reacted with B cells in a manner
similar to the sera under discussion (4) . Recently the technique of antibody-
mediated lymphocyte cytotoxicity has provided evidence for alloantibodies
relating to MLR determinants (12) .
It appears likely that the HL-B antigens described in this report resemble the
la antigens in the mouse . These map with immune response genes and specifi-
cally those of the MLR system (13) . Certain of the sera used in the present study
were analyzed for MLR inhibition and inhibition of specific stimulator cells was
obtained . The la antigen in some studies has been shown to be predominantly on
B cells but evidence implicating T cells also has been obtained (14) .
Summary
A group of alloantibodies are found in pregnancy sera which react with antigens
present on B lymphocytes and monocytes but are not detectable on the vast
majority of unstimulated T cells . This specificity distinguishes them from HL-A
antibodies which react with both cell types . They were readily recognized through
indirect fluorescent antibody analysis by employing the combination of B-cell
lymphoid lines and normal peripheral blood T cells . Different sera gave a variety
of patterns of reactivity with a panel of 11 lymphoid lines . Similar differential pat-
terns were also observed with normal B cells from different individuals particu-
larly after concentrating theB cells. The antibodies were also cytotoxic to B cells
and this procedure gave parallel results to the fluorescence method .
The pattern of reactions obtained indicated a very heterogeneous system
similar to that for HL-A . Special study of certain of the sera provided evidence
that the lymphocyte-defined determinants of the mixed lymphocyte reaction
system were involved . For convenience the term HL-B has been employed for
these antigens .
We are are particularly indebted forthe excellent technical assistance of Mrs. Varda Gilad . Certain of
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Pregnancy
semen
number RPMI
6410 Daudi
RPMI
1788 7301
Lymphoid lines
RPMI
8866 TH B35M MOLT4F A
LeukemicB
B
lymphocytes
C D
058 3* 2 2 0 f 2 4 0 2 2 0 2
057 0 0 0 3 2 2 4 0 3 2 2 2
127 0 0 0 1 2 2 2 0 2 0 0 3
172 0 0 3 3 f 0 0 0 0 2 0 3
ill 1 3 3 3 2 2 3 0 0 2 3 3
007 4 3 1 2 4 4 4 0 2 2 2 3
Normal 0 0 0 0 t 0 0 0 0 0 0 0WINCHESTER ET AL .
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